Publikationen im NUM
Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.
M. Lehmann,
C. Heldt,
J. Meinhardt,
F. Schmidt and
e. a. Rodriguez-Sillke,
"Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells",
Mucosal Immunol,
vol. 14,
pp. 1381—1392,
2021.
M. Lehmann,
C. Heldt and
et al,
"Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells",
Mucosal Immunol,
pp. 1-12,
2021.
| DOI: | 10.1038/s41385-021-00437-z |
J. Barros-Martins,
S. I. Hammerschmidt and
A. Cossmann,
"Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
MedRxiv,
2021.
| DOI: | 10.1101/2021.06.01.21258172 |
| Datei: | https://doi.org/10.1101/2021.06.01.21258172 |
S. Trump,
S. Lukassen,
S. M. Anker,
R. L. Chua,
J. Liebig and
e. a. Thurmann,
"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19",
Nat Biotechnol,
vol. 39,
pp. 705—716,
2021.
| DOI: | 10.1038/s41587-021-00937-2 |
C. Walsh,
P. Tafforeau,
W. Wagner and
et al,
"Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography",
Nat Methods,
vol. 18,
no. 12,
pp. 1532-1541,
2021.
| DOI: | 10.1038/s41592-021-01317-x |
J. Barros-Martins and
et al,
"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
Nature Medicine,
vol. 27,
pp. 1525—1529,
2021.
| DOI: | 10.1038/s41591-021-01449-9 |
D. L. Burnett and
et al,
"Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability",
Immunity,
vol. 54,
pp. 2908—2921.e6,
2021.
| DOI: | 10.1016/j.immuni.2021.10.019 |
E. Schrezenmeier and
et al,
"Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis",
Frontiers in immunology,
vol. 12,
pp. 690698,
2021.
| DOI: | 10.3389/fimmu.2021.690698 |
R. J. Neumann,
B. Kollmann,
J. Brokelmann,
N. M. Werthern,
A. Malsyhau,
D. Weichert,
B. Lutz,
C. J. Fiebach,
M. Wessa and
D. Stahl,
"Impact of COVID-19 lockdown on mental health in Germany: Longitudinal observation of different mental health trajectories and protective factors",
Translational Psychiatry,
vol. 11,
no. 1,
pp. 1—10,
2021.
| DOI: | 10.1038/s41398-021-01508-2 |
B. Mühlemann and
et al,
"Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study",
Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
2021.
| DOI: | 10.1016/j.cmi.2021.06.008 |
B. Mühlemann,
C. Thibeault,
D. Hillus,
E. Helbig,
L. Lippert,
P. Tober-Lau,
T. Schwarz,
M. Müller,
P. group,
M. Witzenrath and
D. Stahl,
"Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study",
Clin Microbiol Infect,
2021.
| DOI: | 10.1016/j.cmi.2021.06.008 |
B. Mühlemann,
C. Thibeault,
D. Hillus,
E. Helbig,
L. Lippert,
P. Tober-Lau,
T. Schwarz,
M. Müller,
P. group,
M. Witzenrath,
N. Suttorp,
L. E. Sander,
C. Drosten,
T. C. Jones,
V. Corman and
F. Kurth,
"Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021;27(10)",
2021.
| DOI: | 1520.e7-1520.e10 |
M. Ricke-Hoch,
E. Stelling,
L. Lasswitz,
A. Gunesch,
M. Kasten,
F. Zapatero-Belinchón,
G. Brogden,
G. Gerold,
T. Pietschmann,
V. Montiel,
J. Balligand,
F. Facciotti,
E. Hirsch,
T. Gausepohl,
H. Elbahesh,
G. Rimmelzwaan,
A. Höfer,
M. Kühnel,
D. Jonigk,
J. Eigendorf,
U. Tegtbur,
L. Mink,
M. Scherr,
T. Illig,
A. Schambach,
T. Pfeffer,
A. Hilfiker,
A. Haverich and
D. Hilfiker-Kleiner,
"Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease",
PLoS One,
vol. 16,
no. 8,
pp. e0255335,
Aug.
2021.
| DOI: | 10.1371/journal.pone.0255335 |
N. Dauletbaev,
S. Kuhn,
S. Holtz,
S. Waldmann,
L. Niekrenz,
B. S. Müller,
C. Bellinghausen,
M. Dreher,
G. G. U. Rohde and
C. Vogelmeier,
"Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol",
BMJ Open,
vol. 11,
no. 9,
pp. e053819,
2021.
| DOI: | 10.1136/bmjopen-2021-053819 |
A. Müller,
F. S. Melzow,
G. Göstemeyer,
S. Paris and
F. Schwendicke,
"Implementation of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers",
International Journal of Environmental Research and Public Health,
vol. 18,
no. 11,
pp. 5710,
2021.
| DOI: | 10.3390/ijerph18115710 |
V. Hennig and
et al,
"Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia",
Orphanet Journal of Rare Diseases,
vol. 16,
pp. 373,
2021.
| DOI: | 10.1186/s13023-021-02011-z |
J. Weiner,
P. Suwalski,
M. Holtgrewe,
A. Rakitko,
C. Thibeault,
M. Müller,
D. Patriki,
C. Quedenau,
U. Krüger,
V. Ilinsky,
E. Helbig,
L. Lippert,
P. Stubbemann,
X. Wang,
Z. Karadeniz,
J. Saccomanno,
J. Doehn,
R. Hübner,
B. Hinzmann,
S. Siemann,
V. Corman,
B. Mühlemann,
C. Drosten,
T. C. Jones,
N. Suttorp,
M. Witzenrath,
S. Hippenstiel,
C. Skurk,
P. Group,
L. E. Sander,
D. Beule,
U. Landmesser,
T. Guettouche,
F. Kurth,
B. Heidecker,
I. Popov,
J. Balnis,
A. Jaitovich,
L. Real,
J. Macías,
J. Pineda,
M. Fernandez-Fuertes,
M. Salvo,
A. Blueher,
S. Jurisic,
J. Beer,
J. Rutishauser,
B. Wiggli,
H. Schmid,
K. Danninger,
R. Binder,
R. Arjun Arkal,
G. Fragiadakis,
E. Mick,
C. Comet,
C. Calfee,
D. Erle,
C. Hendrickson,
K. Kangelaris,
M. Krummel,
P. Woodruff,
C. Langelier,
U. Venkataramani,
F. García,
J. Zyla,
T. Zemojtel,
P. Wolfgang,
T. Borodina and
S. Ripke,
"Increased risk of severe clinical course of COVID-19 in carriers of HLA-C",
04:01. EClinicalMedicine.2021;40:101099,
2021.
J. Weiner,
P. Suwalski,
M. Holtgrewe,
A. Rakitko,
C. Thibeault,
M. Müller,
D. Patriki,
C. Quedenau,
U. Krüger,
V. Ilinsky and
D. Stahl,
"Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01",
EClinicalMedicine,
2021.
| DOI: | 10.1016/j.eclinm.2021.101099 |
S. Dickel,
C. Grimm,
M. Popp,
C. Struwe,
A. Sachkova,
M. Golinski,
C. Seeber,
F. Fichtner,
D. Heise,
P. Kranke,
W. Meissner,
S. Laudi,
S. Voigt-Radloff,
J. Meerpohl,
J. Jabs,
N. Mutters,
O. Moerer and
Group On Behalf Of The German CEOsys Study,
"Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey",
GMS Hyg Infect Control,
vol. 16,
pp. Doc21,
2021.
| DOI: | 10.3205/dgkh000392 |
A. Köster,
A. Bludau,
S. Devcic,
S. Scheithauer,
A. Mardiko and
R. Schaumann,
"Infection surveillance measures during the COVID-19 pandemic in Germany",
GMS hygiene and infection control,
vol. 16,
pp. Doc27,
2021.
| DOI: | 10.3205/dgkh000398 |
A. Köster,
A. Bludau,
S. Devcic,
S. Scheithauer,
A. Mardiko and
R. Schaumann,
"Infection surveillance measures during the COVID-19 pandemic in Germany",
GMS Hyg Infect Control,
vol. 16,
2021.
| DOI: | 10.3205/dgkh000398 |
A. Köster,
A. Bludau,
S. Devcic,
S. Scheithauer,
A. Mardiko and
R. Schaumann,
"Infection surveillance measures during the COVID-19 pandemic in Germany",
GMS Hyg Infect Control,
vol. 16,
2021.
| DOI: | 10.3205/dgkh000398 |
E. Wyler,
K. Eschke,
S. Peidli and
e. a. Pott,
"Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models",
bioRxiv,
2021.
| DOI: | 10.1101/2021.12.17.473180 |
T. Houwaart,
S. Belhaj,
E. Tawalbeh and
et al,
"Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community",
MedRxiv,
2021.
| DOI: | 10.1101/2021.10.18.21264530 |
S. Schroeder,
F. Pott,
D. Niemeyer,
T. Veith,
A. Richter and
e. a. Muth,
"Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics",
Lancet Microbe,
vol. 2,
pp. e210—e218,
2021.
| DOI: | 10.1016/S2666-5247(21)00069-0 |
J. Burns,
A. Movsisyan,
J. Stratil,
R. Biallis,
M. Coenen,
K. Emmert-Fees,
K. Geffert,
S. Hoffmann,
O. Horstick,
M. Laxy,
C. Klinger,
S. Kratzer,
T. Litwin,
S. Norris,
L. Pfadenhauer,
P. Philipsborn,
K. Sell,
B. Stadelmaier,
S. Voss,
K. Wabnitz and
E. Rehfuess,
"International travel-related control measures to contain the COVID-19 pandemic: a rapid review",
Cochrane Database of Systematic Reviews,
vol. 3,
2021.
| DOI: | 10.1002/14651858.CD013717.pub2 |
S. Strobl and
W. Roth,
"Internationale wissenschaftliche Publikationsaktivität zu COVID-19 [International publication activity during the COVID-19 pandemic]",
Pathologe,
vol. 42,
no. 2,
pp. 224-230,
2021.
V. Piechotta,
N. Skoetz,
K. Grummich,
M. Becker,
L. Joos,
G. Becker,
W. Meissner and
C. Boehlke,
"Interventions for palliative symptom control in COVID-19 patients",
Cochrane Database of Systematic Reviews,
vol. 2021,
no. 8,
pp. CD015061,
2021.
| DOI: | 10.1002/14651858.CD015061 |
V. Piechotta,
N. Skoetz,
K. Grummich,
M. Becker,
S. Joos,
G. Becker,
W. Meissner and
C. Boehlke,
"Interventions for palliative symptom control in COVID-19 patients",
Cochrane Database of Systematic Reviews,
pp. CD015061,
2021.
| DOI: | 10.1002/14651858.CD015061.pub2 |
S. Halwe and
et al,
"Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection",
Viruses,
vol. 13,
2021.
| DOI: | 10.3390/v13081498 |
S. Halwe,
A. Kupke,
K. Vanshylla and
et al,
"Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection",
Viruses,
vol. 13,
no. 8,
2021.
| DOI: | 10.3390/v13081498 |
| Datei: | https://doi.org/10.3390/v13081498 |
B. Bošnjak,
I. Odak,
J. Barros-Martins and
et al,
"Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents",
Front Immunol,
vol. 12,
2021.
| DOI: | 10.3389/fimmu.2021.772240 |
| Datei: | https://doi.org/10.3389/fimmu.2021.772240 |
B. Bošnjak and
et al,
"Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents",
Frontiers in Immunology,
vol. 12,
pp. 772240,
2021.
| DOI: | 10.3389/fimmu.2021.772240 |
M. Popp,
M. Stegemann,
M. Metzendorf,
S. Gould,
P. Kranke,
P. Meybohm,
N. Skoetz and
S. Weibel,
"Ivermectin for preventing and treating COVID‐19",
Cochrane Database of Systematic Reviews,
vol. 2021,
pp. CD015017,
2021.
| DOI: | 10.1002/14651858.CD015017.pub2 |
J. J. Malin,
C. D. Spinner,
U. Janssens,
T. Welte,
S. Weber-Carstens,
G. Schälte,
P. Gastmeier,
F. Langer,
M. Wepler,
M. Westhoff,
M. Pfeifer,
K. F. Rabe,
F. Hoffmann,
B. W. Böttiger,
J. Weinmann-Menke,
A. Kersten,
P. Berlit,
M. Krawczyk,
W. Nehls,
F. Fichtner,
S. Laudi,
M. Stegemann,
N. Skoetz,
M. Nothacker,
G. Marx,
C. Karagiannidis and
S. Kluge,
"Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)",
Infection,
2021.
| DOI: | 10.1007/s15010-021-01645-2 |
K. Vanshylla and
et al,
"Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans",
Cell host & microbe,
2021.
| DOI: | 10.1016/j.chom.2021.04.015 |
M. Schmidt,
C. Löwe,
S. Kugai,
A. Thielmann and
B. Weltermann,
"Kommunikations- und Kooperationsstrukturen von Hausärzt*innen und Gesundheitsämtern – Erkenntnisse der egePan-Studie",
DocV-22-02,
2021.
| DOI: | 10.3205/21degam120 |
S. Stillfried,
G. Baretton,
R. D. Bülow,
K. F. Bürrig,
U. H. Holtherm,
D. Jonigk,
R. Knüchel,
R. W. Majeed,
R. Röhrig,
J. Wienströer and
P. Boor,
"Kooperatives Vorgehen der Pathologie und Neuropathologie in der COVID-19-Pandemie : Deutsches Register für COVID-19-Obduktionen (DeRegCOVID) und Deutsches Netzwerk für Autopsien in Pandemien (DEFEAT PANDEMIcs) [Cooperative approach of pathology and neuropathology in the COVID-19 pandemic : German registry for COVID-19 autopsies (DeRegCOVID) and German network for autopsies in pandemics (DEFEAT PANDEMIcs)]",
Pathologe,
vol. 42,
no. 2,
pp. 216-223,
2021.
K. U. Ludwig,
R. M. Schmithausen,
D. Li and
et al,
"LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding",
Nat Biotechnol,
vol. 39,
no. 12,
2021.
| DOI: | 10.1038/s41587-021-00966-9 |
| Datei: | https://doi.org/10.1038/s41587-021-00966-9 |
C. N. Englisch,
T. Tschernig,
F. Flockerzi,
C. Meier and
R. M. Bohle,
"Lesions in the lungs of fatal coronavirus disease COVID-19",
Ann Anat,
vol. 234,
pp. 151657,
2021.
| DOI: | 10.1016/j.aanat.2020.151657 |
S. J. Theobald and
et al,
"Long-lived macrophage reprogramming drives spike protein–mediated inflammasome activation in COVID–19",
EMBO Mol Med,
2021.
| DOI: | 10.15252/emmm.202114150 |
P. Knolle,
N. Körber,
A. Priller and
et al,
"Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination",
Research Square,
2021.
| DOI: | 10.21203/rs.3.rs-677167/v1 |
A. Horn,
L. Krist,
W. Lieb,
F. Montellano,
M. Kohls,
K. Haas,
G. Gelbrich,
S. Bolay-Gehrig,
C. Morbach,
J. Reese and
D. Stahl,
"Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP)",
Infection,
vol. 49,
no. 6,
pp. 1277—1287,
2021.
| DOI: | 10.1007/s15010-021-01707-5 |
A. Horn,
L. Krist,
W. Lieb,
F. Montellano,
M. Kohls,
K. Haas,
G. Gelbrich,
S. Bolay-Gehrig,
C. Morbach,
J. Reese,
S. Störk,
J. Fricke,
T. Zoller,
P. Triller,
L. Kretzler,
M. Rönnefarth,
C. Kalle,
F. Kurth,
F. Steinbeis,
M. Witzenrath,
T. Bahmer,
A. Hermes,
M. Krawczak,
L. Reinke,
C. Maetzler,
J. Franzenburg,
J. J. Vehreschild,
M. Schons,
T. Illig,
G. Anton,
K. Ungethüm,
P. Heuschmann,
T. Keil and
S. Schreiber,
"Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP)",
Infection. 2021;49(6):1277-87. IF: 3.553,
2021.
A. Horn,
L. Krist,
W. Lieb,
F. Montellano,
M. Kohls,
K. Haas,
G. Gelbrich,
S. Bolay-Gehrig,
C. Morbach,
J. Reese,
S. Störk,
J. Fricke,
T. Zoller,
S. Schmidt,
P. Triller,
L. Kretzler,
M. Rönnefarth,
C. Kalle,
S. Willlich,
F. Kurth,
F. Steinbeis,
M. Witzenrath,
T. Bahmer,
A. Hermes,
M. Krawczak,
L. Reinke,
C. Maetzler,
J. Franzenburg,
J. J. Vehreschild,
M. Schons,
T. Illig,
G. Anton,
K. Ungethüm,
P. Heuschmann,
T. Keil,
S. Schreiber,
S. Schmidt,
S. N. Willich,
J. Enderle,
A. Flinspach,
B. C. Finkenberg,
M. T. Gehrig and
N. Savaskan,
"Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).",
Infection. 2021;49(6):1277-87. IF: 3.553,
2021.
P. Tober-Lau and
et al,
"Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers",
The Lancet Respiratory Medicine,
vol. 9,
pp. e104-e105,
2021.
| DOI: | 10.1016/S2213-2600(21)00456-2 |
M. Jan\'ıková,
J. Hodosy,
P. Boor,
B. Klempa and
P. Celec,
"Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in saliva",
Microb Biotechnol,
vol. 14,
no. 1,
pp. 307-316,
2021.
| DOI: | 10.1111/1751-7915.13737 |
S. Contreras,
J. Dehning,
S. B. Mohr,
S. Bauer,
F. P. Spitzner and
V. Priesemann,
"Low case numbers enable long-term stable pandemic control without lockdowns",
Science advances,
vol. 7,
no. 41,
pp. eabg2243,
2021.
| DOI: | 10.1126/sciadv.abg2243 |
A. Kuhlmann,
S. Heinemann,
A. Bludau and
et al,
"Managing protection and surveillance of health workers during COVID-19: German multi-centre survey",
Eur J Public Health,
vol. 31,
no. Supplement 3,
2021.
| DOI: | 10.1093/eurpub/ckab165.441 |
M. Holfelder and
et al,
"Medical Device Regulation Efforts for mHealth Apps during the COVID-19 Pandemic—An Experience Report of Corona Check and Corona Health",
J,
vol. 4,
pp. 206—222,
2021.
| DOI: | 10.3390/j4020014 |